Navigation Links
Telcyta in Medical News

Telik Presents Results at ASCO From ASSIST-5 Trial of TELCYTA in Platinum Refractory and Resistant Ovarian Cancer

PALO ALTO, Calif., May 31 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK ) today announced presentation at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida, of results from the ASSIST-5 Phase 3 randomized, multinational study of TELCYTA(...

Telik Announces Preclinical Presentations at AACR Annual Meeting

...iscovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Fourth Quarter and 2008 Year End Financial Results and 2009 Financial Guidance

.... Telik does not undertake any obligation to update forward-looking statements contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. Telik, Inc. St...

Telik Announces Year-End Financial Release, Conference Call and Webcast

...overy technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...
Telcyta in Medical Technology

Telik Announces Telcyta Clinical and Preclinical Presentations at AACR Meeting

PALO ALTO, Calif., April 09, 2007 /PRNewswire-FirstCall/ -- Telik, Inc. announced that updated clinical data from its multicenter Phase 2 trial of the triplet combination of TELCYTA(R) (canfosfamide HCl, TLK286), carboplatin and paclitaxel will be presented at the 98th annual meeting of the Americ...

Telik Reports Positive Data Demonstrating Synergy in Combination and Highly Statistically Significant Effect of Telcyta as Maintenance Therapy in First-Line Non-Small Cell Lung Cancer

PALO ALTO, Calif., April 17, 2007 /PRNewswire-FirstCall/ -- Telik, Inc. announced the presentation today of results from a Phase 2 clinical trial of the triplet combination of TELCYTA(R) (canfosfamide HCl, TLK286), carboplatin and paclitaxel in the first-line treatment of advanced non-small cell l...

Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome

...very technology, TRAP((R)), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Presentation at ASCO Annual Meeting

...iscovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies

...ik's results to differ materially from those indicated by these forward-looking statements, including, among others, if clinical trials of TELINTRA or telcyta are delayed or unsuccessful, Telik's business would suffer, if Telik's competitors develop and market products that are more effective than its produc...
Telcyta in Biological Technology

FDA Removes Partial Hold on TELCYTA Clinical Development

PALO ALTO, Calif., Oct. 15 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK ) announced that the U.S. Food and Drug Administration (FDA) has removed the partial hold on TELCYTA(R) (canfosfamide HCl, TLK286) clinical trials. This action follows a complete review of TELCYTA data by the agenc...

Telik Announces Second Quarter 2009 Financial Results

...king statements, including, among others, if clinical trials of TELINTRA or telcyta are delayed or unsuccessful, Telik's business would suffer, if Telik's comp...ts contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Reports Preclinical Results at AACR Annual Meeting

...iscovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Implements Reorganization to Focus Resources Toward Drug Development Pipeline

...iodic filings with the SEC. The Company does not undertake any obligation to update forward-looking statements. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Financial Results for 2008 Third Quarter

...2008. Telik does not undertake any obligation to update forward-looking statements contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. Telik, Inc. Statements of Op...

Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer

...ts from an interrupted Phase 3 randomized study of telcyta (canfosfamide HCL) in combination with pegylated l...gression-free survival (PFS) was 5.6 months on the telcyta plus PLD arm compared to 3.7 months on the PLD con...um resistant disease, including 40 patients on the telcyta plus PLD arm and 35 patients on the PLD control ar...

Telik Announces 2008 Third Quarter Financial Release, Conference Call and Webcast

...g discovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces Financial Results For 2008 Second Quarter

...2008. Telik does not undertake any obligation to update forward-looking statements contained in this press release. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. Telik, Inc. Statements of O...

Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast

...g discovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, telcyta and TRAP are trademarks or registered trademarks of Telik, Inc. ...

Telik Announces First Quarter 2008 Financial Results

...oking" statements, including statements regarding the future development of telcyta and TELINTRA. These forward-looking statements are based upon Telik's curre... forward-looking statements, including, among others, if clinical trials of telcyta or TELINTRA are delayed or unsuccessful, Telik's business would suffer, if ...
Other Tags
(Date:7/10/2014)... more likely to be diagnosed with more aggressive ... for shorter times than prostate cancer patients who ... , The negative outcomes may be the result ... mentally ill, depression,s impact on biological cancer processes, ... general health and disinterest in receiving more effective ...
(Date:7/10/2014)... Men who experience hot flashes are unlikely to talk ... their silent suffering if they are willing to ... Baylor University case study., After seven weeks of hypnotic ... flashes following prostate cancer surgery showed a drastic decrease ... improvement in sleep quality, according to the study., The ...
(Date:7/9/2014)... first time, researchers have access to detailed information about ... care. A new study, called Our Health Counts, uses ... faced by urban Aboriginal people in Canada according ... findings, published today in BMJ Open , illustrate ... general population. , Researchers interviewed 554 First Nations adults ...
(Date:7/9/2014)... all types of cancer sends the protein factories in ... tumour,s uncontrolled growth, new research suggests. , Scientists at ... trigger responsible for ratcheting up activity of the endoplasmic ... building blocks cancer cells need to keep growing. , ... controls the flow of messages to the endoplasmic reticulum ...
(Date:7/9/2014)... Cancer Center paint a relatively optimistic picture of women,s ... have spread to the chest wall or skin, but ... skin, regardless of size and whether they have involved ... and called "locally advanced" tumors, suggesting that they are ... survival. Locally advanced breast cancers of this and other ...
Breaking Medicine News(10 mins):Health News:Depressed men with prostate cancer are diagnosed later stage, get less effective therapies 2Health News:Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about 2Health News:Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about 3Health News:Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about 4Health News:Urban Aboriginal people face unique health challenges 2Health News:Signal may send cancer's cellular factories into overdrive 2Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 2Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 3
(Date:7/9/2014)... (July 9, 2014) Emerging fungal pathogens pose ... parasitic group, causing population declines of amphibians, bats, ... University of South Florida published in the prestigious ... acquire behavioral or immunological resistance to a deadly ... , "Acquired resistance is important because it ...
(Date:7/9/2014)... The Cancer Genome Atlas (TCGA) Research Network have ... in lung adenocarcinoma, the most common subtype of ... expand the number of possible therapeutic targets for ... of patients with treatable mutations because many potent ... , TCGA is jointly funded and managed by ...
(Date:7/9/2014)... some shark species may be able to cope with the ... temperatures. , The Arctic today is best known for its ... that. Roughly 53 to 38 million years ago during what ... similar to a huge temperate forest with brackish water, home ... hippo-like creatures, crocodiles and giant tortoises. Much of what is ...
Breaking Biology News(10 mins):USF study: Amphibians can acquire resistance to deadly fungus 2Study identifies novel genomic changes in the most common type of lung cancer 2Study identifies novel genomic changes in the most common type of lung cancer 3Shark teeth analysis provides detailed new look at Arctic climate change 2Shark teeth analysis provides detailed new look at Arctic climate change 3
Other Contents